Skip to main content
Clinical Trials/ACTRN12623000586617
ACTRN12623000586617
Active, not recruiting
未知

An Investigation into the Clinical Performance of the Medacta Masterloc Stem in patients undergoing Total Hip Replacement Procedures

Medacta Australia Pty Ltd0 sites105 target enrollmentMay 30, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Medacta Australia Pty Ltd
Enrollment
105
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 30, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with symptomatic arthritis who are candidates for a primary total hip replacement with an uncemented femoral stem as determined jointly by the surgeon and the patient.
  • Patients able to give informed consent
  • Patients who understand the conditions of the study and are willing to participate for the length of the prescribed follow\-up

Exclusion Criteria

  • Patients who have had a previous total hip replacement or hip fusion of the affected hip
  • Pregnant women or those seeking to become pregnant
  • Patients with a history of active infection
  • Patients who are a prisoner, currently being treated for a psychiatric disorder, senile dementia, Alzheimer’s disease, or known alcohol or substance abuse
  • Patients who are immunologically suppressed

Outcomes

Primary Outcomes

Not specified

Similar Trials